Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology Journal Article

  


Authors: Benson, A. B. 3rd; Venook, A. P.; Cederquist, L.; Chan, E.; Chen, Y. J.; Cooper, H. S.; Deming, D.; Engstrom, P. F.; Enzinger, P. C.; Fichera, A.; Grem, J. L.; Grothey, A.; Hochster, H. S.; Hoffe, S.; Hunt, S.; Kamel, A.; Kirilcuk, N.; Krishnamurthi, S.; Messersmith, W. A.; Mulcahy, M. F.; Murphy, J. D.; Nurkin, S.; Saltz, L.; Sharma, S.; Shibata, D.; Skibber, J. M.; Sofocleous, C. T.; Stoffel, E. M.; Stotsky-Himelfarb, E.; Willett, C. G.; Wu, C. S.; Gregory, K. M.; Freedman-Cass, D.
Article Title: Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology
Abstract: This portion of the NCCN Guidelines for Colon Cancer focuses on the use of systemic therapy in metastatic disease. Considerations for treatment selection among 32 different monotherapies and combination regimens in up to 7 lines of therapy have included treatment history, extent of disease, goals of treatment, the efficacy and toxicity profiles of the regimens, KRAS/NRAS mutational status, and patient comorbidities and preferences. Location of the primary tumor, the BRAF mutation status, and tumor microsatellite stability should also be considered in treatment decisions. © 2017 National Comprehensive Cancer Network, Inc. All rights reserved.
Journal Title: Journal of the National Comprehensive Cancer Network
Volume: 15
Issue: 3
ISSN: 1540-1405
Publisher: Harborside Press  
Date Published: 2017-03-01
Start Page: 370
End Page: 398
Language: English
PROVIDER: scopus
PUBMED: 28275037
DOI: 10.6004/jnccn.2017.0036
DOI/URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85016215716&partnerID=40&md5=459102fde0f31d33e5dd9ca6812a0eae
Notes: Review -- Export Date: 2 May 2017 -- Source: Scopus
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Leonard B Saltz
    790 Saltz
  2. Constantinos T Sofocleous
    244 Sofocleous
Related MSK Work